Symbol
| SPART
| contributors: mct/shn - updated : 22-01-2020
|
HGNC name
| spastic paraplegia 20 (Troyer syndrome)
|
HGNC id
| 18514
|
corresponding disease(s)
|
SPG20
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
hypermethylated in 89p100 of colorectal carcinomas, 78p100 of adenomas and only 1p100 of normal mucosa samples | tumoral
|  
|  
| --low
|  
|
in cancer cells resulted in cytokinesis arrest, which was reversed when SPG20 methylation was inhibited | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
| SPG20 promoter hypermethylation as a biomarker suitable for non-invasive detection of colorectal cancer, and a possible mechanism for cytokinesis arrest in colorectal tumorigenesis |
| | |
| Loss of Spartin in Drosophila induces age-dependent progressive defects resembling hereditary spastic paraplegias, including motor dysfunction and brain neurodegeneration |